(Q38776278)

English

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

scientific article published on 15 May 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

6 September 2017

amyotrophic lateral sclerosis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Writing Group

1

1 reference

Europe PubMed Central

6 September 2017

Edaravone (MCI-186) ALS 19 Study Group

2

1 reference

Europe PubMed Central

6 September 2017

publication date

15 May 2017

1 reference

Europe PubMed Central

6 September 2017

Lancet Neurology

1 reference

Europe PubMed Central

6 September 2017

16

1 reference

Europe PubMed Central

6 September 2017

7

1 reference

Europe PubMed Central

6 September 2017

505-512

1 reference

Europe PubMed Central

6 September 2017

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyotrophic lateral sclerosis: a neurovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxidative stress biomarkers in sporadic ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The administration of guanidine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling drop-outs in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance in the change of decline in ALSFRS-R

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930115-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(17)30115-1

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38776278&oldid=1786497074"